Kansas health regulators issued a joint warning on Wednesday, Feb. 25, saying many retail IV therapy clinics are likely violating the law and potentially endangering patients.
How integrated pharmaceutical manufacturing helps CDMOs simplify scale-up, reduce complexity, and move from raw materials to finished dosage forms faster.
Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy ...
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD ...
GLP-1 medications have changed the conversation around weight management and metabolic health. When prescribed appropriately, ...
Jay Bregman, CEO and co-founder of Andel, discusses how FDA’s action signals a broader regulatory recalibration aimed at protecting intellectual property and explores the second-order effects.
As a physician, former U.S. Surgeon General, and former Indiana State Health Commissioner, my career has been guided by a ...
As a physician, former U.S. Surgeon General, and former Indiana State Health Commissioner, my career has been guided by a ...
An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...
Blue bin 0175 whirred along a conveyer belt in Fairview Health Services’ new automated pharmacy in Shoreview with a big job: ...
Jay Bregman, CEO and co-founder of Andel, discusses how pharmaceutical companies and digital health platforms may need to rethink commercialization strategies, shifting away from costly mass-market ...
The compounds have exploded in popularity, but big questions about safety and effectiveness are still unresolved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results